Transferrin Receptor‐Targeted Nonspherical Microbubbles for Blood–Brain Barrier Sonopermeation
Advanced Materials · 2023-12 · 35 (52)
DOI: 10.1002/adma.202308150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 27.11.2023. Verfasst von Anshuman Dasgupta und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Receptors, Transferrin, Sonication, Microbubbles. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIBIB NIH HHS, European Research Council, NIH HHS.
Abstract (Originalsprache)
Microbubbles (MB) are widely used for ultrasound (US) imaging and drug delivery. MB are typically spherically shaped, due to surface tension. When heated above their glass transition temperature, polymer‐based MB can be mechanically stretched to obtain an anisotropic shape, endowing them with unique features for US‐mediated blood–brain barrier (BBB) permeation. It is here shown that nonspherical MB can be surface‐modified with BBB‐specific targeting ligands, thereby promoting binding to and sonopermeation of blood vessels in the brain. Actively targeted rod‐shaped MB are generated via 1D stretching of spherical poly(butyl cyanoacrylate) MB and via subsequently functionalizing their shell with antitransferrin receptor (TfR) antibodies. Using US and optical imaging, it is demonstrated that nonspherical anti‐TfR‐MB bind more efficiently to BBB endothelium than spherical anti‐TfR‐MB, both in vitro and in vivo. BBB‐associated anisotropic MB produce stronger cavitation signals and markedly enhance BBB permeation and delivery of a model drug as compared to spherical BBB‐targeted MB. These findings exemplify the potential of antibody‐modified nonspherical MB for targeted and triggered drug delivery to the brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, 52074, Aachen, Germany.
- John A. Paulson School of Engineering and Applied Sciences, Harvard University, Boston, MA, 02134, USA.
- Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
- Electron Microscopy Facility, Institute of Pathology, RWTH Aachen University, 52074, Aachen, Germany.
- DWI - Leibniz Institute for Interactive Materials, RWTH Aachen University Hospital, 52074, Aachen, Germany.
ORCID-Profile: Twan Lammers
Förderung
- NIBIB NIH HHS
- European Research Council
- NIH HHS
- European Commission
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
Zitieren
APA
Dasgupta, A., Sun, T., Rama, E., Motta, A., Zhang, Y., Power, C., Moeckel, D., Fletcher, S. M., Moosavifar, M., Barmin, R., Porte, C., Buhl, E. M., Bastard, C., Pallares, R. M., Kiessling, F., McDannold, N., Mitragotri, S., & Lammers, T. (2023). Transferrin Receptor‐Targeted Nonspherical Microbubbles for Blood–Brain Barrier Sonopermeation. Advanced Materials, 35(52). https://doi.org/10.1002/adma.202308150
Vancouver
Dasgupta A, Sun T, Rama E, Motta A, Zhang Y, Power C, et al. Transferrin Receptor‐Targeted Nonspherical Microbubbles for Blood–Brain Barrier Sonopermeation. Advanced Materials. 2023;35(52). doi:10.1002/adma.202308150
BibTeX
@article{Dasgupta2023,
author = {Dasgupta, Anshuman and Sun, Tao and Rama, Elena and Motta, Alessandro and Zhang, Yongzhi and Power, Chanikarn and Moeckel, Diana and Fletcher, Stecia-Marie and Moosavifar, Mirjavad and Barmin, Roman and Porte, Céline and Buhl, Eva Miriam and Bastard, Céline and Pallares, Roger M and Kiessling, Fabian and McDannold, Nathan and Mitragotri, Samir and Lammers, Twan},
title = {Transferrin Receptor‐Targeted Nonspherical Microbubbles for Blood–Brain Barrier Sonopermeation},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {52},
doi = {10.1002/adma.202308150}
}
EUVIMED